A 9-year-old girl is brought to the pediatrician by her mother for follow-up of asthma diagnosed 1 year ago. Over the past 2 months she has used her albuterol inhaler 3 to 4 days per week and has awakened with cough about 3 nights per month. Coughing sometimes makes her stop during soccer games. She went to the emergency department once 6 months ago and has never been hospitalized. She takes no other medications. Her mother smokes outside the home. Her temperature is 37.0°C (98.6°F), pulse is 88/min, respirations are 18/min, and oxygen saturation is 98% on room air. Lungs are clear with a faint end-expiratory wheeze on forced exhalation. Spirometry shows FEV1 84% of predicted, FEV1/FVC 0.80, and a 14% increase in FEV1 after bronchodilator. Inhaler technique is correct. Which of the following is the most appropriate change to her regimen?
- Add daily oral montelukast as the sole controller
- Add daily low-dose inhaled fluticasone
- Add daily oral prednisone
- Add daily inhaled salmeterol as the sole controller
- Schedule albuterol four times daily
Show the answer and explanation
Correct answer: B. Add daily low-dose inhaled fluticasone
Symptoms more than 2 days per week but not daily, and nighttime awakenings 3-4 times per month, with FEV1 >80% of predicted, classify her asthma as mild persistent. The preferred controller for mild persistent asthma in children is a daily low-dose inhaled corticosteroid, which reduces exacerbations and improves lung function more effectively than any alternative. Leukotriene receptor antagonists are an alternative but less effective option, and long-acting beta agonists must never be used without an inhaled corticosteroid.
Why each option is right or wrong
- Add daily oral montelukast as the sole controllerMontelukast is an alternative, less effective step 2 option and also carries a boxed warning for neuropsychiatric effects.
- Add daily low-dose inhaled fluticasoneCorrect: daily low-dose inhaled corticosteroid is the preferred step 2 controller for mild persistent asthma.
- Add daily oral prednisoneChronic systemic steroids are reserved for severe persistent asthma refractory to other therapy because of major adverse effects.
- Add daily inhaled salmeterol as the sole controllerLong-acting beta agonist monotherapy increases asthma-related death and is contraindicated without an inhaled corticosteroid.
- Schedule albuterol four times dailyScheduled short-acting beta agonist provides no anti-inflammatory control and masks worsening disease.
Mild persistent asthma (symptoms >2 days/week, night symptoms 3-4/month, FEV1 >80%): add daily low-dose inhaled corticosteroid; never use LABA monotherapy.
References
- Asthma Medication in Children (StatPearls, NCBI Bookshelf)